Evidence map›Paper›PMID 31130697›Full record

ReviewInternational journal of molecular sciences2019

Role of Nephronectin in Pathophysiology of Silicosis.

Suni Lee, Machiko Honda, Shoko Yamamoto, Naoko Kumagai-Takei, Kei Yoshitome, Yasumitsu Nishimura, Nagisa Sada, Shigeyuki Kon, Takemi Otsuki

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Bicyclol: A Useful Agent for Silicosis?International journal of molecular sciences · 2026
    Review
  3. Review
  4. Review
  5. Characterisation of a COPD-associated nephronectin (The European respiratory journal · 2025
    Article
  6. Article
  7. Article
  8. The role of inflammation in silicosis.Frontiers in pharmacology · 2024
    Review
  9. Review
  10. Animal models of silicosis: fishing for new therapeutic targets and treatments.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Early Detection Methods for Silicosis in Australia and Internationally: A Review of the Literature.International journal of environmental research and public health · 2021
    Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Suni LeeDepartment of Hygiene, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. slee@med.kawasaki-m.ac.jp.
Machiko HondaDepartment of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Gakuen-cho 1, Fukuyama, Hiroshima, Hiroshima 729-0292, Japan. honda@fukuyama-u.ac.jp.
Shoko YamamotoDepartment of Hygiene, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. s.yamamoto@med.kawasaki-m.ac.jp.
Naoko Kumagai-TakeiDepartment of Hygiene, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. kumagai@med.kawasaki-m.ac.jp.
Kei YoshitomeDepartment of Hygiene, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. kei_y@med.kawasaki-m.ac.jp.
Yasumitsu NishimuraDepartment of Hygiene, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. yas@med.kawasaki-m.ac.jp.
Nagisa SadaDepartment of Hygiene, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. nagisada@okayama-u.ac.jp.
Shigeyuki KonDepartment of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Gakuen-cho 1, Fukuyama, Hiroshima, Hiroshima 729-0292, Japan. kon@fukuyama-u.ac.jp.ORCID 0000-0001-5410-8429
Takemi OtsukiDepartment of Hygiene, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. takemi@med.kawasaki-m.ac.jp.
Kawasaki Medical School · JPFukuyama University · JPOkayama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silicosis is a typical form of pneumoconiosis and is characterized as a type of lung fibrosis. Silica particles are captured and recognized upon by alveolar macrophages via the macrophage receptor with collagenous structure (MARCO) scavenger receptor, and thereafter the inflammasome is activated. Thereafter, various chemokines/cytokines play their roles to eventually form fibrosis. Additionally, silica particles chronically activate T helper cells which sets the background for the formation of silicosis-associated autoimmune disturbances. The occurrence and progression of lung fibrosis, the extracellular matrix-related molecules such as integrins and their ligands including fibronectin, vitronectin, laminin, and collagens, all play important roles. Here, the roles of these molecules in silicosis-related lung fibrosis are reviewed from the literature. Additionally, the measurement of serum nephronectin (Npnt), a new member of the integrin family of ligands, is discussed, together with investigations attempting to delineate the role of Npnt in silica-induced lung fibrosis. Serum Npnt was found to be higher in silicosis patients compared to healthy volunteers and seems to play a role in the progression of fibrosis with other cytokines. Therefore, serum Npnt levels may be employed as a suitable marker to monitor the progression of fibrosis in silicosis patients.

Indexed as

AnimalsExtracellular Matrix ProteinsHumansInflammationLungOccupational DiseasesPulmonary FibrosisSilicon DioxideSilicosisExtracellular Matrix ProteinsnephronectinSilicon Dioxideextracellular-matrixfactor analysisnephronectinserum concentrationsilicosis

Identifiers

PMID31130697
PMCPMC6566895
OpenAlexW2945273677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.